Exfoliative erythroderma: Difference between revisions

 
(8 intermediate revisions by 3 users not shown)
Line 1: Line 1:
==Background==
==Background==
{{Skin anatomy background images}}
*Also known as exfoliative dermatitis
*Also known as exfoliative dermatitis
*Diffuse, widespread scaly dermatitis that covers most of body surface
*Diffuse, widespread scaly dermatitis that covers most of body surface
Line 7: Line 8:


==Clinical Features==
==Clinical Features==
*Generalized erythema, warmth, scaling
[[File:Red (burning) Skin Syndrome - Feet Collage.jpg|thumb|Erythroderma]]
*Can be pruritic and painful
*Generalized [[rash|erythema, warmth, scaling]]
*Can be [[pruritus|pruritic]] and painful
*Abrupt onset if related to drug, contact allergen, or malignancy; gradual onset if related to underlying cutaneous disorder
*Abrupt onset if related to drug, contact allergen, or malignancy; gradual onset if related to underlying cutaneous disorder
*Generally starts on face and trunk with progression to other skin surfaces
*Generally starts on face and trunk with progression to other skin surfaces
Line 17: Line 19:
*[[Erythema multiforme]]
*[[Erythema multiforme]]
*[[Stevens-Johnson syndrome and toxic epidermal necrolysis]]
*[[Stevens-Johnson syndrome and toxic epidermal necrolysis]]
*[[Toxic shock syndrome]]
*[[Drug rash]]
*[[Staphylococcal scalded skin syndrome]]
*Drug eruption
*[[DRESS syndrome]]
*[[DRESS syndrome]]
{{Erythematous rash DDX}}


==Evaluation==
==Evaluation==
===Workup===
*CBC, CMP, ESR
*CBC, CMP, ESR
*[[CXR]]
*[[CXR]]
*Determine underlying cause, including evaluation for underlying malignancy and biopsy of skin
*Determine underlying cause, including evaluation for underlying malignancy and biopsy of skin
===Diagnosis===
{{Table of severe drug reactions}}


==Management==
==Management==
*Emergent dermatology consult
*Emergent dermatology consult
*Fluid replacement for hypovolemia, monitor fluid intake
*[[Fluid replacement]] for [[hypovolemia]], monitor fluid intake
*Warming measures for hypothermia
*Warming measures for [[hypothermia]]
*Wound care
*Wound care
*Discontinue all unnecessary medications
*Discontinue all unnecessary medications
*Systemic corticosteroids after dermatology consult
*Systemic [[corticosteroids]] after dermatology consult
*Antibiotics if evidence of secondary infection
*[[Antibiotics]] if evidence of secondary infection


==Disposition==
==Disposition==
Line 46: Line 52:


==See Also==
==See Also==
*[[Rash]]
*[[Erythematous rash]]


==External Links==
==External Links==

Latest revision as of 16:24, 11 December 2024

Background

Normal dermal anatomy.
  • Also known as exfoliative dermatitis
  • Diffuse, widespread scaly dermatitis that covers most of body surface
  • Cutaneous reaction to a drug or chemical agent or underlying systemic or cutaneous disease
  • Males affected twice as often as females
  • Most patients >40 years old

Clinical Features

Erythroderma
  • Generalized erythema, warmth, scaling
  • Can be pruritic and painful
  • Abrupt onset if related to drug, contact allergen, or malignancy; gradual onset if related to underlying cutaneous disorder
  • Generally starts on face and trunk with progression to other skin surfaces
  • Low-grade fever common
  • Tends to be a chronic condition, mean duration 5 years

Differential Diagnosis

Erythematous rash

Evaluation

Workup

  • CBC, CMP, ESR
  • CXR
  • Determine underlying cause, including evaluation for underlying malignancy and biopsy of skin

Diagnosis

Table of Severe Drug Rashes

Charateristic DRESS SJS/TEN AGEP Erythroderma
Image PMC3894017 JFMPC-2-83-g001.png Stevens-johnson-syndrome.jpg Acute generalized exanthematous pustulosis.png Red (burning) Skin Syndrome - Feet Collage.jpg
Onset of eruption 2-6 weeks 1-3 weeks 48 hours 1-3 weeks
Duration of eruption (weeks) Several 1-3 <1 Several
Fever +++ +++ +++ +++
Mucocutaneous features Facial edema, morbilliform eruption, pustules, exfoliative dermattiis, tense bullae, possible target lesions Bullae, atypical target lesions, mucocutaneous erosions Facial edema, pustules, tense bullae, possible target lesions, possibl emucosal involvement Erythematous plaques and edema affecting >90% of total skin surface with or without diffuse exfoliation
Lymph node enlargement +++ - + +
Neutrophils Elevated Decreased Very elevated Elevated
Eosinophils Very elevated No change Elevated Elevated
Atypical lymphocytes + - - +
Hepatitis +++ ++ ++ -
Other organ involvement Interstitial nephritis, pneumonitis, myocarditis, and thydoiditis Tubular nephritis and tracheobronical necrosis Possible Possible
Histological pattern of skin Perivascular lymphocytcic infiltrate Epidermal necrosis Subcorneal pustules Nonspecific, unless reflecting Sezary syndrome or other lymphoma
Lymph node histology Lymphoid hyperplasia - - No, unless reflecting Sezary syndrome or other malignancy
Mortality (%) 10 5-35 5 5-15

Management

Disposition

  • Admit

Complications

See Also

External Links

References

  • Tintinalli's Emergency Medicine 7th Edition, pg 1614, 1617
  • Harwood-Nuss' Clinical Practice of Emergency Medicine 6th Edition, pg 821